Patient information
了解Profil的新动态。
在该页面上您可以找到有关Profil的当前新闻。您可以阅读有关Profil以及作为临床研究组织,与我们工作相关的更多信息。此外,我们还将讨论糖尿病创新领域相关制药或技术公司高度关注的有趣话题。
如有任何疑问或意见,请随时使用右侧的联系按钮与我们联系。
Lars Bochmann 博士
市场与业务发展执行总监
一月 16, 2025
Introduction Obesity is a chronic complex disease contributing to the development of various obesity-related comorbidities, such as metabolic syndrome and dysfunction, type 2 diabetes, cardiovascular
read more
十二月 18, 2024
The QT interval is an electrocardiographic parameter that has gained considerable importance in the safety evaluation of drugs. Background QT is measured from the beginning of the Q wave until the
十一月 14, 2024
The euglycemic hyperinsulinemic glucose clamp technique is the gold standard for the determination of pharmacokinetic (PK) and pharmacodynamic (PD) effects of (new) glucose lowering drugs, insulins
九月 30, 2024
Artificial Intelligence (AI) has rapidly become a transformative force across numerous industries, and clinical research is no exception. The integration of AI into clinical research is
九月 10, 2024
We are happy to announce that our successful series of scientific online seminars continues. On October 08th, 2024 at 4:00PM CEST we will air our next complimentary live online seminar. The session
八月 27, 2024
The regulatory landscape for medical device manufacturers in the EU has changed significantly with the introduction of new regulations. Navigating these requirements can be challenging, but with the
七月 31, 2024
Germany is on the brink of a pivotal transformation in the pharmaceutical research landscape with the upcoming Medical Research Act. This legislative milestone is part of the government's broader
七月 4, 2024
We are happy to announce that our successful series of scientific online seminars continues. On July 30th, 2024 at 6 PM CEST we will air our next complimentary live online seminar. The session is
五月 29, 2024
In the constantly evolving landscape of the biotech industry, small and medium-sized enterprises (SMEs) in Europe are finding an invaluable ally in Contract Research Organizations (CROs). Among